纳米输送系统作为的有希望的治疗潜力:目前的状况和未来的前景
Ahmad Movahedpour1, Rasul Taghvaeefar1, Ali-Akbar Asadi-Pooya2,3
1Behbahan Faculty of Medical Sciences, Behbahan, Iran.
CNS neuroscience & therapeutics
|July 15, 2023
概括
纳米颗粒对通过血脑屏障 (BBB) 输送抗发作药物 (ASM) 显示出希望,以治疗. 外体对合成纳米颗粒具有潜在的优势,可以改善ASM传递和治疗.
科学领域:
- 神经学 神经学
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 是一种慢性神经系统疾病,其特征是异常的神经元电活动.
- 抗发作药物 (ASM) 是的主要治疗方法,但药物耐药性是一个重大挑战.
- ASM 穿越血脑屏障 (BBB) 的有限能力有助于治疗耐药性.
研究的目的:
- 审查基于合成纳米粒子的药物输送系统,用于ASM.
- 讨论这些纳米输送系统的好处和局限性.
- 探索外体作为一种新且有前途的治疗的药物输送平台.
主要方法:
- 关于纳米粒子和基于外体的类药物输送现有文献的叙事综述.
- 对研究合成纳米粒子用于ASM输送的研究进行分析.
- 讨论与药物输送相关的外体属性.
主要成果:
- 合成纳米颗粒显示出跨越BBB并提高ASM有效性的潜力.
- 已经探索了各种合成纳米粒子配方用于ASM交付.
- 在药物输送应用中,外体对合成纳米粒子具有独特的优势.
结论:
- 基于纳米粒子的系统提供了一个有前途的策略,可以克服ASM的BBB限制.
- 外体代表着下一代药物输送系统,在治疗方面具有显著的潜力.
- 对外体介导分娩的进一步研究可能会导致的治疗结果得到改善.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
349
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
349
Arteries of the Lower Limbs
215
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
215
Antiepileptic Drugs: Sodium Channel Blockers
682
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
682
Antiepileptic Drugs: Glutamate Antagonists
427
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
427
Antiepileptic Drugs: GABAergic Pathway Potentiators
467
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
467
Antiepileptic Drugs: Potassium Channel Activators
215
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
215


